Cell line · CVCL_0454
SNU-449
Cancer cell line, Homo sapiens. Adult hepatocellular carcinoma. 52 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SNU-449. Cell lines, record CVCL_0454. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0454
On this page
Cell line
As Cellosaurus gives it.
- Name
- SNU-449
- Accession
- CVCL_0454
- RRID
- RRID:CVCL_0454
- Synonyms
- SNU449, NCI-SNU-449
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 52Y
- Category
- Cancer cell line
- Diseases
- Adult hepatocellular carcinoma (NCIt C7956); Adult hepatocellular carcinoma (ORDO Orphanet_210159)
- Derived from
- Liver (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers52
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Enabling subcellular DESI-MSI for broad adoption: Acquisition, analysis, and application. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RBM25 Drives Hepatocellular Carcinoma Progression by Stabilizing YAP Through Regulating Oncogenic Splicing-switch of MYPT1. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Epigenetic silencing of the liver-specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| An SLCO2B1 mRNA Isoform Acts as a Noncoding RNA to Drive Cancer Progression by Triggering Protein Biosynthesis. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TGFβ1 Activates Lnc-APUE to Promote Tumor Metastasis via the Alu Element-Driven STAU1-Mediated Decay of CDH1 mRNA. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mechanical Stimuli-Induced Manipulation of Malignant Behavior in Bioprinted Cancer Microtissues via PI3K/NF-κB Activation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A novel candidate tumor biomarker progestin and adipoQ receptor 3 regulates cell metastasis through transforming growth factor-β pathway in hepatocellular carcinoma. | Cytojournal | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Peptide‑based therapeutics targeting the SLC39A14‑PIWIL2 fusion in hepatocellular carcinoma. | Genomics Inform | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 52
See all 52 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE SNU-449-Cas9 | CVCL_F5P7 | Cell lines | |
| Derived from it | EDITGENE SNU-449-CopGFP | CVCL_F6C0 | Cell lines | |
| Derived from it | SNU-449/Cas9-hyg | CVCL_C9G7 | Cell lines | |
| Derived from it | SNU449/GPC3-OE | CVCL_F6L8 | Cell lines | |
| Derived from it | SNU449/Vector | CVCL_F6L9 | Cell lines |
Cell banks5
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0454
GET https://conductscience.org/api/cell-lines/v1/CVCL_0454/papers?page=2